Showing results (1-10 of 79) with videos related to
Sort By:
Pageof 8
Trends in Molecular Medicine|August 1, 2018
Genetic and Phenotypic Diversification of Heterogeneous Tumor PopulationsDavid L Elion, Rebecca S CookSeminars in Immunopathology|September 7, 2018
Efferocytosis in the tumor microenvironmentThomas A Werfel, Rebecca S CookOncotarget|July 11, 2018
Harnessing RIG-I and intrinsic immunity in the tumor microenvironment for therapeutic cancer treatmentDavid L Elion, Rebecca S CookOncotarget|March 19, 2015
Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?Michelle M Williams, Rebecca S CookBreast Cancer Research : BCR|December 6, 2015
Dual inhibition of Type I and Type III PI3 kinases increases tumor cell apoptosis in HER2+ breast cancersChristian D Young, Carlos L Arteaga, Rebecca S CookJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 3, 2016
Mouse Models of Breast Cancer: Platforms for Discovering Precision Imaging Diagnostics and Future Cancer MedicineH Charles Manning, Jason R Buck, Rebecca S CookJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2017
Functional Optical Imaging of Primary Human Tumor Organoids: Development of a Personalized Drug ScreenAlex J Walsh, Rebecca S Cook, Melissa C SkalaCancer Cell & Microenvironment|December 22, 2017
Efferocytosis creates a tumor microenvironment supportive of tumor survival and metastasisDavid B Vaught, Jamie C Stanford, Rebecca S CookCancer Medicine|September 28, 2021
MLL3 is a de novo cause of endocrine therapy resistanceKimberly M Stauffer, David L Elion, Rebecca S Cook, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2018
Biological Consequences of MHC-II Expression by Tumor Cells in CancerMargaret L Axelrod, Rebecca S Cook, Douglas B Johnson, et al.Pageof 8